CymitQuimica logo

CAS 290297-26-6

:

Netupitant

Description:
Netupitant is a selective neurokinin-1 (NK1) receptor antagonist primarily used in the prevention of nausea and vomiting associated with chemotherapy. It is often combined with palonosetron, a 5-HT3 receptor antagonist, to enhance its efficacy. The molecular formula of netupitant indicates that it contains carbon, hydrogen, nitrogen, and oxygen atoms, reflecting its organic nature. This compound is characterized by its high affinity for the NK1 receptor, which plays a crucial role in the emetic response. Netupitant is typically administered orally and is well-absorbed in the gastrointestinal tract. Its pharmacokinetics show a relatively long half-life, allowing for once-daily dosing. The substance is generally well-tolerated, with common side effects including fatigue, constipation, and headache. Due to its mechanism of action, netupitant is particularly effective in managing chemotherapy-induced nausea and vomiting, making it a valuable therapeutic option in oncology settings.
Formula:C30H32F6N4O
InChI:InChI=1S/C30H32F6N4O/c1-19-8-6-7-9-23(19)24-17-26(40-12-10-38(4)11-13-40)37-18-25(24)39(5)27(41)28(2,3)20-14-21(29(31,32)33)16-22(15-20)30(34,35)36/h6-9,14-18H,10-13H2,1-5H3
InChI key:InChIKey=WAXQNWCZJDTGBU-UHFFFAOYSA-N
SMILES:N(C(C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1)=O)(C)C=2C(=CC(=NC2)N3CCN(C)CC3)C4=C(C)C=CC=C4
Synonyms:
  • 2-[3,5-Bis(trifluoromethyl)phenyl]-N-[6-(4-methylpiperazin-1-yl)-4-o-tolylpyridin-3-yl]-N-methylisobutyramide
  • Benzeneacetamide, N,alpha,alpha-trimethyl-N-(4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)-3-pyridinyl)-3,5-bis(trifluoromethyl)-
  • Benzeneacetamide, N,α,α-trimethyl-N-[4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)-3-pyridinyl]-3,5-bis(trifluoromethyl)-
  • N,α,α-Trimethyl-N-[4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)-3-pyridinyl]-3,5-bis(trifluoromethyl)benzeneacetamide
  • Netupitan
  • Netupitant
  • Ro 67-31898/000
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
  • Ref: IN-DA002V9C

    1g
    93.00€
    5g
    181.00€
    25g
    To inquire
    100mg
    46.00€
    250mg
    61.00€
  • Netupitant

    CAS:
    Netupitant
    Purity:≥98%
    Molecular weight:578.59g/mol

    Ref: 54-BUP13389

    5mg
    76.00€
    10mg
    104.00€
    25mg
    185.00€
    50mg
    290.00€
    100mg
    503.00€
    200mg
    741.00€
  • 2-(3,5-Bis(Trifluoromethyl)Phenyl)-N,2-Dimethyl-N-(6-(4-Methylpiperazin-1-Yl)-4-(O-Tolyl)Pyridin-3-Yl)Propanamide

    CAS:
    2-(3,5-Bis(Trifluoromethyl)Phenyl)-N,2-Dimethyl-N-(6-(4-Methylpiperazin-1-Yl)-4-(O-Tolyl)Pyridin-3-Yl)Propanamide
    Purity:99%
    Molecular weight:578.59g/mol

    Ref: 54-PC109174

    1g
    83.00€
    5g
    261.00€
    25g
    834.00€
    100mg
    32.00€
    250mg
    48.00€
  • Netupitant

    CAS:
    Formula:C30H32F6N4O
    Color and Shape:White To Off-White Solid
    Molecular weight:578.60

    Ref: 4Z-N-075001

    5mg
    To inquire
    10mg
    349.00€
    25mg
    444.00€
    50mg
    635.00€
    100mg
    To inquire
  • NETUPITANT

    CAS:
    Purity:95%
    Molecular weight:578.60302734375

    Ref: 10-F856948

    1g
    74.00€
    5g
    224.00€
  • Netupitant

    CAS:
    Netupitant (CID 6451149) is a specific neurokinin 1 (NK1) receptor antagonist (Ki: 0.95 nM).
    Formula:C30H32F6N4O
    Purity:99.43%
    Color and Shape:Solid
    Molecular weight:578.59
  • Netupitant

    Controlled Product
    CAS:
    <p>Applications Netupitant is a potent and selective neurokinin-1 receptor (NK1) receptor antagonist. It is achiral and orally active.<br>References Hoffmann, T., et al.: Bioorg. Med. Chem. Lett., 16, 1362 (2006); Di Fabio, R., et al.: Bioorg. Med. Chem., 21, 6264 (2013)<br></p>
    Formula:C30H32F6N4O
    Color and Shape:Neat
    Molecular weight:578.59

    Ref: TR-N390950

    10mg
    161.00€
    50mg
    389.00€
    500mg
    1,672.00€
  • Netupitant

    CAS:
    <p>Netupitant is an antiemetic drug that is used to treat bowel disease. It has been shown in a two-way crossover study to have biological properties in the treatment of disease activity. Netupitant inhibits the neurokinin-1 receptor and matrix effect, which are responsible for the development of cancerous cells. The drug also has inhibitory properties on p-gp substrates and netupitant, which prevents it from being absorbed by the gastrointestinal tract. This allows netupitant to be transported through the blood-brain barrier into malignant brain tumours, where it can act as a cytotoxic agent.</p>
    Purity:Min. 95%

    Ref: 3D-FN103430

    250mg
    1,830.00€
    500mg
    2,130.00€